Nuveen Asset Management, LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 157 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2024$2,182,808
-47.8%
89,643
-27.6%
0.00%0.0%
Q1 2024$4,182,920
-31.9%
123,865
-36.4%
0.00%
-50.0%
Q4 2023$6,138,323
+23.6%
194,682
+0.2%
0.00%0.0%
Q3 2023$4,965,541
-8.1%
194,346
+3.2%
0.00%0.0%
Q2 2023$5,401,362
+152008.2%
188,332
+27.1%
0.00%
+100.0%
Q1 2023$3,551
+205.3%
148,164
+116.1%
0.00%
Q4 2022$1,163
-99.9%
68,547
-37.7%
0.00%
-100.0%
Q3 2022$1,631,000
-4.6%
110,088
+1.4%
0.00%0.0%
Q2 2022$1,709,000
-23.7%
108,606
-23.9%
0.00%0.0%
Q1 2022$2,239,000
-36.3%
142,658
+50.3%
0.00%0.0%
Q4 2021$3,513,000
-28.9%
94,925
-33.1%
0.00%
-50.0%
Q3 2021$4,938,000
+13.9%
141,833
+10.7%
0.00%
+100.0%
Q2 2021$4,337,000
+34.0%
128,172
-29.0%
0.00%0.0%
Q1 2021$3,236,000
-22.5%
180,466
-9.0%
0.00%0.0%
Q4 2020$4,178,000
+34.8%
198,413
+174.5%
0.00%0.0%
Q3 2020$3,100,000
+6.1%
72,277
+15.6%
0.00%0.0%
Q2 2020$2,923,00062,5320.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
Portolan Capital Management 484,907$11,807,4850.97%
Nikko Asset Management Americas, Inc. 1,563,065$37,966,8490.44%
Diametric Capital, LP 32,765$797,8270.43%
ARK Investment Management 1,964,964$47,846,8710.42%
SummerHaven Investment Management, LLC 23,400$569,7900.38%
Quantedge Capital Pte Ltd 40,800$993,4800.36%
Granahan Investment Management 344,549$8,389,7680.34%
FEDERATED HERMES, INC. 4,694,060$114,300,3610.27%
Belmont Capital, LLC 40,000$974,0000.18%
Woodline Partners LP 754,023$18,360,4600.18%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders